Testosterone News and Research

Latest Testosterone News and Research

Scientists define genetic cause for two types of birth defects in newborn boys

Baylor College of Medicine scientists defined a previously unrecognized genetic cause for two types of birth defects found in newborn boys, described in a report published today in the journal Nature Medicine.

2 Jun 2014

Men who feel stressed have fewer, slower sperm

Psychological stress is harmful to sperm and semen quality, affecting its concentration, appearance, and ability to fertilize an egg, according to a study led by researchers Columbia University's Mailman School of Public Health and Rutgers School of Public Health.

30 May 2014

FDA approves Trimel’s Natesto nasal gel to treat adult males with low testosterone

Trimel Pharmaceuticals Corporation announced today that the United States Food and Drug Administration (FDA) has approved Natesto (testosterone), formerly CompleoTRT, the first and only testosterone nasal gel for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.

29 May 2014

Trimel announces top-line results of Phase II clinical trial evaluating efficacy of Tefina

Trimel Pharmaceuticals Corporation (TSX: TRL) announced today top-line results of its Phase II clinical trial evaluating the efficacy and safety of Tefina™, a "use-as-required" testosterone nasal gel for the treatment of Female Orgasmic Disorder (FOD).

28 May 2014

Auxilium Pharmaceuticals presents new XIAFLEX clinical trial data at AUA Meeting

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced that new analyses of data were presented from its clinical program and pivotal IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials, the Phase 3 studies that evaluated XIAFLEX® (collagenase clostridium histolyticum or CCH) for the treatment of Peyronie's disease (PD).

19 May 2014

USPTO grants two additional patents to SeroVital-hgh formula

SeroVital®-hgh, the "Fountain of Youth" Formula everyone's talking about, has been making headlines ever since a group of some of the most renowned researchers in the world revealed that this oral compound is actually capable of increasing mean, endogenous, serum (blood) human growth hormone (hGH) levels by 682%. Experts everywhere — from dermatologists and obesity researchers to women's healthcare providers and even the famed Dr. Oz himself — began paying attention to this groundbreaking formula.

19 May 2014

Study examines predictors and effects of testosterone therapy

Three new studies examining the predictors, effects and durability of testosterone therapy on men will be presented to reporters at the 109th Annual Scientific Meeting of the American Urological Association (AUA) during a special press conference in the Orange County Convention Center, Orlando, FL on Sunday, May 18 at 2:00 p.m. ET.

19 May 2014

TOLMAR Pharmaceuticals holds exclusive distribution rights to ELIGARD in the U.S. and Puerto Rico

TOLMAR Pharmaceuticals, Inc., focused on specialty pharmaceutical products, today announced that, effective May 8, 2014, the company holds exclusive distribution rights to ELIGARD® (leuprolide acetate for injectable suspension) in the U.S. and Puerto Rico.

16 May 2014

Antares Pharma reports total revenues of $5.2 million for first quarter 2014

Antares Pharma, Inc. today reported operating and financial results for the first quarter ended March 31, 2014.

9 May 2014

Low levels of testosterone associated with more aggressive prostate cancer

For men with low-risk prostate cancer, low levels of testosterone may indicate a worsening of their disease. That's the conclusion of a new study published in BJU International.

5 May 2014

Physicians call for large clinical trials to assess risks associated with testosterone treatment

Physicians do not have sufficient information from clinical trials to understand the risks associated with the prescription of testosterone in older men, according to a Comment in The Lancet Diabetes & Endocrinology, written by Professor Stephanie Page, of the University of Washington and Harborview Medical Center, Seattle, USA.

29 Apr 2014

First Edition: April 28, 2014

Today's headlines include a number of stories examining the impact of the health law in various states.

28 Apr 2014

Findings shed light on evolution of mammalian behaviors and their brain mechanisms

A team led by scientists at The Scripps Research Institute has deciphered the surprisingly versatile code by which chemical cues help trigger some of the most basic behaviors in mice.

26 Apr 2014

New simple screening questionnaire designed to identify testosterone-deficient men

Men whose testosterone falls below normal levels are more likely to have erectile dysfunction and to be overweight and have heart disease and type 2 diabetes.

25 Apr 2014

Men's health conditions may be influenced by exposure to testosterone in womb, says study

Men's susceptibility to serious health conditions may be influenced by low exposure to testosterone in the womb, new research suggests.

23 Apr 2014

Scientist receives $1.8M defense grant from Kessler Foundation for spinal cord injury research

Kessler Foundation has been named awardee of a three-year grant for $1.8 million from the Department of Defense Spinal Cord Injury Research Program. Gail Forrest, PT, PhD, is principal investigator for the randomized, double-blinded, controlled, multi-site clinical trial, which will test strategies to improve bone and muscle strength after spinal cord injury. Dr. Forrest is assistant director of Human Performance & Engineering Research at Kessler Foundation.

18 Apr 2014

NICE recommends FIRMAGON for treating advanced hormone-dependent prostate cancer in adults with spinal metastases

The National Institute for Health and Care Excellence (NICE) today issued its Final Appraisal Determination (FAD) recommending FIRMAGON (degarelix) as an option for treating advanced hormone-dependent prostate cancer, only in adults with spinal metastases who present with signs or symptoms of spinal cord compression.

16 Apr 2014

6 months of hormonal treatment in addition to radiotherapy improves outcome for prostate cancer

Vienna, Austria: Men with prostate cancer that is small and confined to the prostate gland but that is at risk of growing and spreading, do better if they are treated with radiotherapy combined with androgen deprivation therapy, which lowers their levels of the male hormone, testosterone, according to new research.

7 Apr 2014

Vestiage completes R&D for two new products

Vestiage™, Inc., the emerging leader in healthy aging, announced today that it has completed R&D for two new products that it intends to launch in upcoming quarters.

2 Apr 2014

Educational intervention program for children reduces aggressive behavior later in life

An educational intervention program for children between kindergarten and 10th grade, known as Fast Track, reduces aggressive behavior later in life, according to research published in Psychological Science, a journal of the Association for Psychological Science.

2 Apr 2014

Testosterone News and Research

Latest Testosterone News and Research

Scientists define genetic cause for two types of birth defects in newborn boys

Men who feel stressed have fewer, slower sperm

FDA approves Trimel’s Natesto nasal gel to treat adult males with low testosterone

Trimel announces top-line results of Phase II clinical trial evaluating efficacy of Tefina

Auxilium Pharmaceuticals presents new XIAFLEX clinical trial data at AUA Meeting

USPTO grants two additional patents to SeroVital-hgh formula

Study examines predictors and effects of testosterone therapy

TOLMAR Pharmaceuticals holds exclusive distribution rights to ELIGARD in the U.S. and Puerto Rico

Antares Pharma reports total revenues of $5.2 million for first quarter 2014

Low levels of testosterone associated with more aggressive prostate cancer

Physicians call for large clinical trials to assess risks associated with testosterone treatment

First Edition: April 28, 2014

Findings shed light on evolution of mammalian behaviors and their brain mechanisms

New simple screening questionnaire designed to identify testosterone-deficient men

Men's health conditions may be influenced by exposure to testosterone in womb, says study

Scientist receives $1.8M defense grant from Kessler Foundation for spinal cord injury research

NICE recommends FIRMAGON for treating advanced hormone-dependent prostate cancer in adults with spinal metastases

6 months of hormonal treatment in addition to radiotherapy improves outcome for prostate cancer

Vestiage completes R&D for two new products

Educational intervention program for children reduces aggressive behavior later in life

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Testosterone News and Research

Latest Testosterone News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in